Please upgrade your browser.
Our Facebook poll asks you to give your opinion regarding privacy of electronic health records. Are they safe?
Learn about the MDX-1106 clinical trial and proposed funding cuts for NIH/NCI in our daily newscast.
Dr. Martha Boone, an Atlanta urologist, explains the consequences of the new health care law. Because of her fears about Obamacare, Boone moved to a less-expensive office so she could avoid dropping Medicare patients or laying off an employee.
Aveo Pharmaceuticals, Inc. announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name ficlatuzumab (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.
If there's to be a train wreck, we governors would rather be spectators than conductors. But if the federal government is willing to reroute the train to a different, more productive track, we are here to help.
The current edition of Kidney Cancer News, the Association's period newsletter, is available online.
EntreMed, Inc. (Nasdaq:ENMD - News), today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor.
|Powered by NeonCRM|